Figure 2:

Cumulative incidence of development of common post-HT co-morbidities

Caption: Cumulative incidence of post-transplant lymphoproliferative disease (PTLD; 2a), coronary artery vasculopathy (CAV; 2b), first hospitalization for infection (2c), and first hospitalization for rejection (2d). Patients with heterotaxy syndrome (dotted line) are compared to other patients with congenital heart disease (solid line). Cumulative incidence is calculated for each group with the competing outcome of death/retransplant (these curves are not illustrated for clarity). Statistical comparison of curves performed as described by Pepe and Mori.